Abstract
Colorectal cancer (CRC) is one of the most common in the world and its chemotherapeutic treatment is considered aggressive due of the several adverse effects observed, which include those for the first-choice drug: 5-fluorouracil (5-fu). As a result of its low oral bioavailability and short plasma half-life, this drug is administered intravenously at high dosage and frequency, which, comb…